Insulet Expands Omnipod 5 and Omnipod Discover to Middle East
Event summary
- Insulet launched Omnipod 5 and Omnipod Discover in Saudi Arabia, Kuwait, Qatar, and UAE.
- Omnipod 5 is now available in 19 countries globally, with plans to expand to Spain in 2026.
- Omnipod Discover is a proprietary data analytics platform for Omnipod 5 users.
- The Omnipod 5 System is compatible with Abbott FreeStyle Libre 2 Plus and Dexcom G7 sensors.
The big picture
Insulet's expansion into the Middle East marks a strategic move to address unmet needs in regions with high diabetes prevalence. The launch of Omnipod Discover underscores the company's focus on data-driven diabetes management, aligning with broader industry trends towards personalized healthcare solutions. With plans to enter Spain, Greece, and Croatia, Insulet is positioning itself for further global growth in the automated insulin delivery market.
What we're watching
- Market Penetration
- How Insulet will leverage the Middle East launch to drive adoption in high-need regions.
- Regulatory Approvals
- The pace at which Insulet secures approvals for Omnipod 5 in additional countries.
- Competitive Dynamics
- Whether Insulet can maintain its lead in tubeless insulin pump technology against competitors.
Related topics